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This exarnination consists of two glcti.ong.
ScotLon A consists of 100 multiple choice questions.
Eectioa B consists of tuo (Z) long questions.
Answer ALL questions.
Answer to section A must be entered into the scripts provided.
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gECTION A
1. Which of the following statenents is true?
(A) Congestive cardiac failure (Ccf) occurs when
there is transient myocardial ischemia,
(B) CCF resul.ts when the }eft, right or both
ventricles fal1 to pump sufficient blood to
meet the bodyrs needs.
(C) CCF occurs with chronic anemia because cardiac
index is greatly dininished.
(D) Digoxin is the drug of choice in the treatment
of CCF.
2. Which of the following statements is true?
. . o . . (A) CCF occurs more cornmonly in the males.
(B) CCF occurs more cornmonly in the youngpatient than the old.
..... (C) The use of digoxin in CCF is associated with a
reduced nortality rates.
.... o (D) Hyperthyroidisn is an example of disease that
can result in low output CCF.
3. Which of the following is not a deterninant of cardiac
workload?
(A) Preload.
(B) Contractility.
(c) Heart size.
(D) Subendocardial perfusion.
228
. . .31-
(FcP 551)
INDEX NO.:
4. Which of the following statements is false?
..... (A) In heart failure an increase in preload is
associated with a dininished cardiac output'
(B) The preload of the heart will increase when
cardiac output is reduced in heart failure'
(C) Hlpertension is one of the main causes of CCF'
(D) The body compensates for the loss in cardiacfunction by decreasing heart size.
5. l{hich of the following statements is true?
(A) Vasodilators are not used in CCF because they
cause hypotension.
(B) There is an abnornal retention of sodium by
the kidneys in CCF.
(c) Patients with ccF should not be allowed to have
bedrest because it can cause venous thrombosis.
(D) The goal in the use of the diuretic therapy in-hearf failure is to reduce body.weight by 1-2 kgper day in adults.
6. Which of the following statements is true?
(A) Potent diuretics usually act on the proximal
'tubules.
(B) Thiazide diureti.cs act on the proxinal portion
of the ascending looP of Hen1e.
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(c) spironolactone is the preferred diuretic when
rbnal function is verY Iow.
(D) Thiazide diuret,ics are useful because they do
not cause overdiuregis.
7 , I{hich of the following statements is true?
.|...(A)Digoxinisprirnaritye}iminatedintheliver.
o..,. (B) Hypercalcenia can be cauEed by thiazidediuretics.
(C) Hyperuricemia can be caused by frusemide'
(D) Spironolactone can causte hyperkalemia'
S.Whichofthefollowingstatenentsistrue?
'..o,(A)TheactionoffrusemideinheartfailureisindePendent of renal function'
(B) The use of thiazide is preferred to the use of
irusemide because thiazide causes Less
hYPokalemia.
(c) Captopril can reverae some of the secondary
tryierifaosteronism associated with ccF'
(D) Hydralazine is the preferred vasodilator inpatients with CCF.
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guoetlon 9 - 13 r.trr to tbo tollollag oltcl
A 54 year old l,[alay man was admitted to the hospital for
shortireqs of breatlr, reduced effort tolerance andparoxysnal nocturnal dyspnea. A STAT BUSE result hras
as follows:
Blood urea L2.2 mrnol/LPotassium 3.2 rnnol/l,Sodium L22 nnol/L
As part of the management of the patient, the doctor orderedthe following drugs:
i. Digoxin o.5mg stat.ii. Frusemide iv 40ng stat and BD'iii. Tab Potassium Chloride 600 mg BD'iv. AmPicillin.IV 5OO ng QID.
9. Which of the following statements is true regarding the abovepatient?
..t..(A)Frusernideshouldnotbegiven.IYilthispatient
because it oan aggravate hlpokalenla'
(B)Potassiunadministratj.onwouldresultin
hyperkaienia.
..... (c) Thiazide would be the preferred diuretic in thispatient.
i.... (D) The dose of digoxin is appropriate'
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10. Which of the following is the paraneter of least importancefor monitoring the above patient?
(A) Haemoglobin.
(B) White cell count.
(C) Blood urea.
..... (D) Serum potassium
11. Which of the following drugs would be the best in terms
of acutely rnanaging the above patient?
. c . .. (A) Gentamicin.
(B) Captopril
(C) Propranolol.
(D) Sodium nitroprusside.
72. Iflrich of the following drugs is not indicated in the abovepatient,?
..o.. (A) Morphine.
..... (B) Pethidine.
...,. (C) Theophylline.
(D) Thiazide.
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13. Which of the following statenents about this patient is
false?
(A) The patient should be fLuid restricted'
(B) Hypertonic saline solution is indicated for the
treatnent of hYPonatremia.
(c) ACE inhibitors may be ueeful to correct
hypokalemia.
. '... (D) Diuresis can be induced by bed rest'
14. Which of the following is not important in deciding the route
of frusemide adrninistiation in patients with CCf?
. . . .. (A) Cost.
(B) Onset of action.
(c) Amount of diuresis.
(D) BioavailabilitY.
15. Which of the follosing statements regarding the use ofdigoxin in CCF is true?
(A) There is a good correlation between plasma
concentration and clinical effect.
(B) Digoxin use is associated wj-th reduced rnorbidity
and mortalitY.
...., (c) Digoxin can induce diureeis.
(D) The risk of toxicity is increased by
hyperkalemia.
|rr ar f)
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16. Which of the foLlowing statements jg false?
(A) Temporary sinus tachycardia is normal after
vigorous exercise.
..... (B) Atrial and ventricular muEcle cel1s cannotproduce ectopic activity.
(C) Abnormal inpulse fornation is the cause ofparoxysmal supraventricular tachycardia (SVT) .
. o... (D) Breatnent of arrhythmia are most often selected
on an ernpirical basis rither than scientificbasis.
L7. l{hich of the fol}owing is not an antiarrhythnic drug?
.. ,.. (A) Phenytoin.
(B) Propranolol.
(C) I'{exilitene.
..... (D) Nifedipine.
18. Which of the f,ollowing statements is true?
(A) Atrial fibrillation is associat,ed with
significant morbidity and mortaLity.
(B) Lidocaine is the drug of choice in the treatment
of atrial fibrillation,
(C) The use of digoxin is contraindicated in atrialfibrillation.
(D) Nifedipine given via the intravenous route is a
euitable choice for atrial fibrillation.
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19. Which of the following statements is true?
o.... (A) Quidinine is nainly rnetabolised in the liver.
. . . , . (B) procainarnide is lnainly elinrinated in the kidney.
(C) Venaparnil can cause tachycardia"
(D) Corneal microdeposition is a known side effect
of bretyLiun.
2A. Which of the following statenents l€ falEe?
(FCP 551)
(A) Verapamil is suitable for use in paroxysinal
supriventricular tachYcardia.
(B) Digoxin is suitable for use in first degree
atrioventricular block.
(c) Quinidine syncope is sometimes called trtorsadede Pointesrr.
(D) Prornpt treatment is eesential in ventricularfiUrillation because it is universally fatalif persistent.
, . . .. (c) Quinidine may reduce pJ-asma digoxin
concentrati-on.
(D) Sodium nS"troprusside is contraindicated in heartfailure.
2L, llhich of the following staternents is true?
.....(A)Formanypatientswithout}ifethreatening
arrythnial or major electrolyte disturbances,
witirolding digitirts is sufficient in the
treatment of aigitatis intoxication'
(B) The rnajor difference between digitoxin anddigoxii is the route of administration'
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22. Which of the following is false about doparnine?
(A) It acts by increasing myocardial contractility.
o... o (B) It can cause tachycardia.
(c) Tolerance is known to occur with its prolonged
, use.
(D) High doses can cause reduced renal" perfusion.
23. Which of the fol-lowing drugs is not known as a cause of CCF?
(A) PredniEolone.
.. .. , (B) Adrianycin.
... o. (C) Indomethacin.
(D) Paracetamol.
24. Which of the following is not an adverse drug reactj.on ofprocainanide?
(A) Systenic lupus erythenatosus.
.. !.. (B) Negative inotroPY.
(C) Proarrythrnic.
(D) PhotosensitivitY.
25. Which of the following is not useful for increasing cardiac
output in CCF.
(A) Bed rest.
(B) Fluid challenge.
(C) Dobutamine.
(D) Captopril.
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26. t{hich of the following is the least carcinogenic asbestos?
.... r (A) ChrYsotil,e.
. r... (B) Crocidol.ite.
(C) Tremolite.
..... (D) Amosite.
27. Which of the following cell type is the most prominent
component of early leiionE in asbestosis?
..... (A) LlmPhocYLes.
...,. (B) MacroPhaqtes.
(C) Fibroblasts.
(D) NeutroPhils.
28. The incidence of bronchogenic carcinoma among smoking
asbestos workers is i.ncreased by . .... . r. ' folds'
(A) 5
(B) 10
(c) 30
(D) 40.
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29. The clinical syrnptoms and radiographic features of
asbestosis usually appear at least ....... years
after pat,ients initial contact with asbestos.
..... (A) 2
..... (B) 5
(c) 10
..... (D) 20
30. Which of the following is the most severely affected
anatomic region in asbestosis?
(A) The lung aPices.
(B) The right middle lobe.
(c) The lower lobes.
(D) The portions of the lung abutting on the
mediastinum.
(rcP 551)
the following is a specific treatment of silicosis?
Antibiotics.
Bronchodilators.
Diuretics.
Corticosteroids.
31. Which of
(A)
(B)
(c)
(D)
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32. Which of the following is/are observed in asbestosis but notin Eilicosis?
(i) Prominent granulomatous lung response'
(ii) Increased susceptibirity to rnycobacteriuninfection.
(iii) Extensive damage to lung parenchyma'
(iv) Increased risk to lung nalignancy'
..... (A) (i) and (iii) onIY.
...,. (B) (ii) and (iv) onlY.
..... (C) (i) (ii) and (iii) onIY'
(D) (iv) onIY.
33. l{hich of the following area of the lung is ruostly aff ectedin silicosis?
..... (A) The uPPer lobes.
...., (B) The niddle lobes.
(C) The lower lobes.
(D) The portions of the lung abutting on the
mediastinum.
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34. Rspi.rin induced bronchospasrn by increasing ttre production
of . .....
..... (A) leukotrienes C4 and D4.
(B) IgG.
.,... (C) IgE.
(D) Prostaglandln E.
35. The incidence of bronchospasm induced by iodine containing
contrast media could be prevented by pretreatment
with ,. ,. .. .. .
(A) aninophylLine.
(B) salbutanol.
(C) chlorpheniranine.
(D) indonethacin
36. The most conmon drug that caused noncardiogrenic pulmonary
edema (NCPE) is intravenous. . . . . . . .
. . . . . (A) hydrochlorothiazide.
..r.. (B) heroine.
(C) bleomycin.
(D) terbutaline.
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37. Which of the following statenents regarding drug-induced
hypersensitive lung disease is true?
(A) Prognosis is verY Poor.
'. o.. (B) occurs after chronic drug exposure'
(C) pulmonary function tests abnornalities are very
specific.
(D) Chest radiograph shows diffuse acinar infiltrate
and pleural effusion.
38. Which of the following mechanisn is involved in carmustine-
induced lung fibrosis?
..... (A) Inhibition of glutathione reductase'
..... (B) Generation of superoxide anions'
(c) Induction of pulmonary inflamuratory reaction.
..... (D) Increased collagen deposltion'
39. Which of the foLlowing conditions predispose(s) patient todigitalis-induced arrhYthnia?
(i) Hyponagnesemia.
(ii) Hypercalcenia.
(iii) Hypokalenia.
(iv) Hyperuricenia.
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..... (A) (i) and (iii) only.
o 6... (B) (ii) and (iv) onIY.
..... (c) (i), (ii) and (iii) only,
(D) (iv) only.
40. I{hich of the following drug should be avoided in the
treatment of digoxin-induced arrhythnia?
..,.. (A) Procainanide.
(B) Quinidine.
(C) Lidocaine,
..... (D) Phenytoin.
41. Which of the following type of ventricular arrhythmia is the
earliest indication of digitalis t'oxicity?
.. o. r (A) BradYcardia.
...., (B) Fibrillation.
...., (c) Tachycardia.
r.... (D) EctoPic beats.
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42. The most inportant risk factor associated with increase risk
of myocardial infarction in current oral contraceptive usersis.... ...
(A) smoking.
(B) hyperlipoproteinenia.
(C) diabetes nellitus.
(D) hypertension.
43. Which of the foLlowing is contraindicated in the treatment
of tricyclic antidepressant (TCA) overdose?
(A) Sodium'bicarbonate.
(B) Procainamide.
(c) Phenytoin.
(D) Lidobaine.
44. In TCA overdose, cardiac arrest and death is most prominent
within the first ...,. hours.
(A) L2
..... (B) 24
..... (c) 36
.. .. . (D) 48
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45. The recommended dose of estrogen content in oral
contraceptive pill is
(A) 1!ncs.
. .. ., (B) 30mcg.
..... (C) 60mcg.
..o.. (D) 90mcg.
46. !{hich of the following statement regarding hypertension(HTN) is true?
(A) The riEk of cardiovascular complications are
related to the level of systolic and diastolic
blood pressure,
(B) The risk of cardiovascular conplications are
related to the duration of the diseases.
(C) The risk of cardiovascular complications are not
related to the drug theraPY.
(D) The risk of cardiovascular complications are
related to the non-drug therapy.
47. Which of the following is the drug of choice in HTN with
congestive heart failure?
(A) Nitroprusside.
..... (B) Hydralazine.
(C) Diazoxide.
(D) Clonidine.
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48. Which of the following drug is used only in step IV inthe management of HTN?
(A) Hydrochlorothiazide.
..... (B) Clonidine.
(c) Guanithidine.
..... (D) Captopril
49. Which of the following diuretic is not associated with
alteration of lipid profile?
(A) Hydrochlorothiazide.
(B) Chlortalidone.
(C) Spironolactone.
(D) Indaparnide.
. 50. Which of the following adverse reaction of beta-blockers is
associated with its lack of ISA?
(A) Bronchoconstriction.
(B) Heart block.
(c) cNs.
(D) Cold extrenitis.
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51. l{hich of the following vasodilator is capabte of causingpriapisn?
(A) Prazosin.
(B) Hydrallazine.
... r. (c) Nitroprusside.
(D) Diazoxide.
52. Which of the following vasodilator is useful in the
nanagement hypertension with renal faiLure?
(A) Diazoxide.
o... o (B) Hydrallazine.
(c) Nitroprusside.
(D) Clonidine.
53. Which of the following vasodllator act mainly on the veins?
(A) Nitroprusside.
..... (B) Diazoxide
(C) Prazoslne.
(D) Hydrallazine.
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54. I{hich of the following vaEodilator is the most common
cause of cyanlde toxicitY?
(A) Hydrallazine.
..... (B) Prazogin.
(C) Diazoxide.
(D) Nitroprusside.
55. Which of the following vasodilator iE commonly associated
with tachycardia?
(A) Hydratlazine.
..... (B) Prazosine.
(c) Diazoxide.
(D) Nitroprusside.
56. !{hich of the following vasodilator is asEociated with
hyperglycemia?
.... o (A) HYdrallazine.
(B) Prazosin.
(C) Diazoxide.
(D) NitroPrusside.
247
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Which of the following vasodilators is
with first dose postural hlpotension?
always associated
(A) Hydrallazine.
(B) Prazosin.
(C) Diazoxide.
(D) Nitroprusside'
5g. Which of the fol'lowing vasodilator have a strong asEociation
with systemic luPus erYthematons?
(A) Hydrallazine.
(B) Prazosin.
(C) Diazoxide.
(D) Nitroprusside.
Sodium thiosulfate is usually given to
reaction of the following vasodilator?
prevent the adverse
(A) Hydrallazine.
(B) Prazosin.
(c) Diazoxide.
(D) Nitroprusside.
59.
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60.
61.
(A) Hydrallazine.
(B) Prazosin.
(C) Diazoxide.
(D) Nitroprusside.
which of the following diuretic
effects?
has a potassium retention
62.
(A) Thiazide.
(B) Mannitol.
(C) Spironolactone.
(D) Frusemide.
which of the following drugs ispatent ductus atriosus (PDA)?
commonlY used to cLose the
(A) Indomethacin.
(B) NaprosYn.
(C) Digoxin.
(D) Frusemide.
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63. Which of the following drug is the best choice in theprevention of rheunatic heart diseases?
.,,.. (A) Penicillin G.
(B) Gentanycin.
... o. (c) Ceftazidine.
(D) Co-trinoxazole
64. Which of the following drug is the best choice in theprevention of enrbolisrn in rheumatic heart disease?
(A) Aspirin.
(B) Naprosyn.
. .. . . (C) Piroxican.
(D) Indomethacin.
65. Which of the following bronchodilator is useful in apnea?
(A) S0lbutamol.
(B) Bricanyl,
(c) Theophylline.
(D) fpratropium Bromide.
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66. Which of the following antihypertensive drug is conmonly
associated with alteration of Laste?
(A) Enalapril.
(B) Captopril.
(C) Clonidine.
(D) Methyldopa.
67. I{hich of the following antihypertensive drugr is a potentinducer of sore throat?
(A) Enalapril.
(B) Captopril.
(c) Clonidine.
(D) Methyldopa.
68. Which of the foLlowing antihypertensive drug is not
recomrnended in a young hypertensive man?
(A) EnalapriI.
(B) Captopril.
(C) Clonidine.
(D) Methyldopa.
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69. Which of the following antihypertensive drug is usedin hypertensive urgencY?
(A) EnalaPriI.
(B) CaPtoPril.
(c) Clonidine.
(D) MethyldoPa.
70. AIl Of the fOIlOWing except ....... decreases oxygen
utilization bY the mYocardium.
. ... . (A) anemia
(B) tachYcardia
..... (c) decreased ventricular volume
(D) obstruct,ion of the coronary arteries
7L, All of the following are risk factors of atherosclerotic
coronary artery diseaEe except........ '
(A) smoking
(B) hypertension
(c) obesitY
(D) hypertriglYceridernia
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72. Nitroglycerin results in all of the following. Which one isIeast likely to play a role in relieving pain of myocardial
ischemia in routine use?
,.... (A) venous dilatation
.. r.. (B) Arterial hypotension
.. . r , (C) coronary 
.artery dilatation
.,,.. (D) Tachycardia
73. which of the following statement is/are true regardingprinzmetalrs angina?
(i) It, results from spasm of coronary arteries
(ii) It is often improved by digitalis and diuretics
(iii) It may occur with normal coronary arterieE
(iv) It is associated with development of transient
Q waves in the electrocardiogram.
(A) (i) and (iii) only
(B) (ii) and (iv) only
(c) (i), (ii) and (iii) only
.' :. . (D) (iv) onlY
253
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74. Which of the following ls not related to the action of
calciun channel blockers?
..... (A) They have no effect on conLraclililty
... i. (B) They reducee ventricular volume
...,. (C) They are primary venodilators
.. o.. (D) TheY reduces afterload
75. AII of the following islare bronchodilator except.....
(i) ketotifen
(ii) beclomethaeone valerate
(iii) crornolYn sodium
(iv) ipratropium bromide
(A) (i) and (iii) onlY
,.... (B) (ii) and (iv) onlY
(c) (i), (ii) and (iii) onlY
o .. . . (D) (iv) onIY
(rcP s51)
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76. Which of the following combination is true ?
(A) Ipratropium bromide - effective in chronicbrochitis
(B) Theophylline - effective for the prevention of
exercLse induced asthma
(C) Inhaled steroid - effective in acute asthmatic'
attack.
.,... (D) Inhaled cronolyn - effective in childhood asthma.
77. Which of the following is the agent of choice in patients
with unstable angina ?
(A) Sublingual nifediPine
.. o.. (B) Intravenous nitroglycerin
.. r.. (c) Intravenous propranolol
..... (D) oral diltiazen
78. Which of the following'statement is/are true regarding
cromolyn ?
(i) It inhibit the early but not,.the late asthnatic
response to inhaled antigen in atopic asthma'
(ii) Maximum effect of cromolyn is usually seen
4-6 weeks of treatment.
(iii) It possesses an extrernely potent anti-inflam-
natory activitY.
(iv) Its use is linited for prophylaxis of asttrma
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o.... (A) (i) & (iii) onIY
..... (B) (ii) & (iv) onlY
(c) (i), (ii) & (iii) onIY
..... (D) (iv) onlY
79. prolonged use of cromolyn with one of the agent. listed below
rnay de6rease bronchial lryperactivity and prevent. usual iI
' in}rease in bronchial hyperactivity seen in atopic asthma.
... .. (A) $teroid
.,... (B) TheoPhY}line
(C) IPratroPium
(D) Beta-agonist
go. t{hich of the following aerosol corticosteroid possess thegreatest relative topical potency ?
(A) Beclornethasone-17,21-dipropionate
(B) Flunisolide
(c) Dexamethasone sodiun phosphate
..... (D) Budesonide
91. Which of the following aerosol corticosteroid is expected
to give the no3t extensive systemic effects ?
(A) Beclomethasone-17, 21-dipropionate
(B) Flunisolide
(C) Dexamethasone sodiun phosphate
(D) Budesonide
...3L1-
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82- which of_the forrowing responses hrirl be affected bytolerance developed fion ling-term use of beta-adreirergicreceptor agonists ?
...,. (A) Tremor
.... r (B) Heart rate
. .. .. (C) Llnnphocyte and 1eukocyte cAllp 1evels
... o. (D) All of the above
83. The pharmacologicar features of ipratropium bromideincludes....
(A) complete protection against histamine-inducedbronchospasm.
" .. ' (B) no protection against exercise-induced bronchialconstriction
. r r.. (c) more effective than beta-2-agonist in asthma
. . r. . (Di none of the'above
84'. which of the following effect have been reporLed to beassociated with rv is6proterenol in severe asthmatics ?
..... (A) Myocardial ischenia
o..., (B) Myocardial_ infarction
..,. r (C) Death
(D) All of the above
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85. Anginal pain is classically termtnated rapidly by....
(A) lidocaine
(B) quinidine
. o... (c) nitroglycerin
(D) digitalis
96. The type of angina that most often occurs after the patient
has experienced physical stress is caI}ed,...
..... (A) nocturnal angina
(B) unstable angina
(C) angina of effort
..,.. (D) Prinznetalrs angina
87. The letter rAr in the term SOAP stands for..
(A) appropriate symptomat,ic information
.. r.. (B) action plan
...,. (c) all obJective information
..... (D) assessment of the problem
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88. Mr. AA is a 55 year-old nan with problems of heart failure,
diabetes (Type II), and hypertension.
Which of the following pharnacistrs action plan is
appropriate to assees digoxin therapy, assuming thatMr. AArs failure is becoming worse ?
P : observe patient for fatigue and signs
of digoxin toxicitY
P : give more digoxin until the 
.heart rate slowsto 60
P : order digoxin serun concentration, serun
potassiuru, and aEsess patient compliance.
P : no monitoring required
89. Which of the following is a major functions in clinical
monitoring of drug therapy ?
. c... (A) Identification of actual or potential drug
related problen.
..... (B) Resolving actual drug related problem.
..... (C) Preventing drug related problem.
..... (D) All of the above.
(A)
(B)
(c)
(D)
259
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90. Which of the following describe the Pharmacist l{orkup of
Drug Therapy (PWDT) ?
(A)
(B)
A fornat to specifically check prescribing error
by doctors.
A forrnat to calculate the cost-effectiveness of apharnacist activities.
A format for docurnenting pharmacist clinicalinterventlon and activities.
A format for physical assessnent of patients,
Too little of the correct drug.
Patient non-compliance behaviour.
Patient who snoke 2 pack a day on theophylline
therapy.
All of the above.
(c)
(D)
91. Which of the following is an exarnple of drug relatedproblen?
(A)
(B)
(c)
(D)
92. Which of.the following is not true regarding the purpose of
a pharmacist problern list ?
..... (A) To ensure that physician has ordered all the
necessary laboratory tests.
,.... (B) To ensure that all nedical problems are being
addreEsed.
To determine the appropriateness of the drugprescribed.
To determine parameters for continued monitoring
of drug therapy.
(c)
(D)
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analgesic is usuallY Preferable in asthmatics who havepain ?
(A) Ibuprofen
(B) Aspirin
(C) Paracetamol
.(D) NaprosYn.
in sorne94. Which inhaled agent causes oral candidiasispatients?
.. .. . (A) Salbutamol
(B) IPratroPiurn
..... (c) Triamcinolone
o. r,. (D) CromolYn
lthich inhaled beta agonist
action?
.. r.. (A) Salbutanol
.. ... '(B) Terbutaline
...,. (C) MetaProterenol
r... . (D) IsoProterenol
has the shortest duration of95.
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96. Which therapeutic agent is the first choice in the emergency
room treatment of asthma ?
..... (A) Nebulized atropine sulfate'
..... (B) Inhaled cromolYn
(c) Inhaled beta-2 agonist
..... (D) Oral theoPhY1line
97. which therapeutic agent should be considered if inhaled
beta-2 agonist are not sufficient in the treatment of
out-patient asthrnatic ?
..... (A) oral Prednisolone
..... (B) oral theoPhYlline
(e) Inhale cromolYn
..... (D) oral nifediPine
98. Which of the following dosing tirne is appropriate for
alternate daY steroid theraPY ?
(A) 6-8 AItl
(B) 6-8 PIt{
(c) 1-3 P!'t
. . . .. (D) 10-11 Alil
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gg. What is the usual theophylline half-tife (in hours) in
. 
children of aged 1 - 9 Years ?
..... (A) L2 hr.
.o... (B) 10 hr'
(c) 8 hr'
(D) 4 hr.
LOO. Which of the following is true regarding the purpose of
early steroid therapy for chronic asthma ?
.... o (A) To abort the inflamatory process'
..... (B) To, decrease bronchial hyperactivity'
i. 
'.. 
(c) To regulate the pulmonary beta-2 receptors'
(D) To facilitate the tapering of theophylline dose.
2S3
. . .381-
38 (FcP s51)
INDEX NO.:
Stclrof, B
Qucgtl.on 1
A 54 year old Malay man presented to the clinic with thefollowing complaintE:
1. Shortness of breath.2. Bilateral ankle swelling.3. Lightheadedness.
Past medical history was significant for hypertension,
diabetes meLlitus and ischemic heart disease. ?he patient
denied any history of rheumatic heart disease or thyroiddisease. He however adnitted to smoking a pack of
cigarettes for the past 30 years.
Physical exarnination :
BP 130/80 nrnllg ; Pulse : 140 beats/nin.Respiration 18/ninute ; temperature 37.1"C.Chest was clear but cardiac examinations revealed anirregularly rhythm without murmurs or gallops. JVP wag
sightly elevated.
a:iltting edena wae noted bilaterally on the ankles
Electrocardiogram revealed atrial fibrillation and
chest X-ray vtas consistent with nild cCF.
Define atrial fibrillation. What was the patienthistory that couLd have led this patient to have
atrial fibrillation.
( 2 narks)
B. Define your goals in treating this patient?
( 3 narks)
...391-
A.
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INDEX NO.:
lfhat other history is to be ericited in this patient togauge whether or not he i" ? candiditJ--ro, drugtreatment to restore and rnaina;il-;;;;"i sinus rythm?
(rcP 551)
(10 narks)
_thg patient be treated, whatExplain.
c.
D. If it is so decided thatare your alternatives?
Quostlon 2
vA is a 67 vears ord chinese nan was adnitted to HusM for thestabilizatioi of his blood pressure.
II{VA is a known hypertensive
adnltted on and off to HUStt
HPT
was
Ir!tsDIcATroNS gA
1. HCTZ i b.d.2. Propranolol i tds.3. Atenolol. i tds4, PrazoEin 0.5 mg b.d.5. prazosin 1 ng 6.d.
On examination : Bp 1BO/130,
Ros:
HCNNr : Blurring
1989.
(1O narks)
patient slnce last 45 yeara.for uncontrolled hypertlnsion.
1948 19801956 1986.1986 today.1988 19901990 today.
P:95 RR:2b T . 3Z.s
of vision with (R) cataract removed
He
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INDEX NO.:
CHEST ! A/E:good.
r.,irng : Crepitation both sides with
- dullness at base of both 1mg'
CVS I DRNM
Abd : L:l S:1 Ko
Ext. I Numbness of fingers and toe'Others : t{NL'
Laboratory finding :
Na : 135 K:3.5 UtLT Glucose:5'5SrCr :
Others not done.Provisional diagnosis : Uncontrolled HTN'Renal insufficiencY.
Management : Continue previous treatment'
A. Comment on the current treatment of I'Ir' V'A'
( 10 Marks )
B. The doctor wants to start ACE inhibitor therapy inlllr. v.A.
(i) Briefly discuss the advantages and- disadvantags of
ACE inirinitor in the treatnrent of HTN with renalinsufficiency.
(ii) Reconnend a suitable drug regimen from the grouP of
ACE inhibitor for the management of his problems.
( 15 Marks )
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Appendix
Normal Laboratcry Values 
.
1. Ammonia 80-110 mcgldl or 4T-65 unrol/L
2. Amilase 4-ZS fulnl
3. Billirubin
Direct 0-C.2 ng/gl O-3 urnoJ./L
rndirect O . Z-C. g mg/af 3 O-14 urnbf Tf,Total O.Z-L mg/dl 3O-L7 umot/L
4. Caz zo-30 mEq/L 24-30 nMol/L
5. pCOZ 3S-4S nmHg
6. Cr 100-106 mEg/L 100-106 nMol/L
7. cpk So-r7o u/L
8. creat,inine (scr) o. 6-L. 5 m9ld1 60-130 urnol/L
9. Random blood sugar 7O-LLO ng/dl 3-10 umol/L
L0. fron 5O-L5O rncgldl g , A-26.9 unol/L
11. Lactic jA-ZtO TU|Ldehydrogenase
12. Magnessium L.s-z. o rnEq/L O. g_1. 3 mMoI/L
L3. pOZ 75-100 mrnHg
L4. pH 7 .35-7 .45
15. , Acid phosphataseMale o . i3 -o . 63 ru/m1 36-17 6 nmol 
"-1l1,Fernale 0. iO1-0. 65 f U/[rI 2 . g-],56 nmol s-l/t
L6. Alkaline 39-LL7 IU/Lphosphatase
t7. Phosphorous 3.C-4.S mg/dl 1.0-1.5 nMol/L
L8. Potassium (K+) 3. S-5.0 nEq/L 3.5-5.0 mMol/L
L9. Calcium (caz+) 8.5*l-O.S rng/dl z.L-2.6 mMol/L
20. Sodium (Na+) i35-i45 nrEg/L 135-145 nrMolll,
2r. Bj-carbonate (Hco3-) 2t"-38 nEg/L z4-z8 mMol/L
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22. Protein
TotaI 6.0-8.5 gldL 60-85 glLAlbunin 3.5-5.0 g/dl 35-sO 9/Lclobulin 2.3-3.5, g/dl . 23-35 g/LTransferrin 200-400 mg/dl 2.O-9.O glL
23. Transaminase 0-40 TUIL
(sGoT)
24. BUN
25. Uric Acid
26. Blood Pictures
8-25 ng/dl
3-7 mg/dI
Red blood cell (RBC) 
^ 
?Male 4.8-6"4 x 101/runlFenale 4.2-5.4 x lOo/mmJ
White blood ceII(WBC) 4.0-11.0 x 1OJ/mmrP 60-75t
L 20-402
M 4-82B 0-1?
E 1-38
Platelate (PIt) 2oo-4oo x 103/nn3
27. ESR Male O-10 mn/jan (Wintrobe)
Fema1e 0-15 mn/jan (Wintrobe)
28. Hematocrit
MaIe 45-522Fema1e 37-482
29. Hemoglobine (Hgb)
MaIe L3-18 q/dl
Female 12-L6 g/dl
30., Prothrornbin tine 75-lA0Z nilai asas
(PT)
31. APTT 25-37 saat
32, Creatinine 105-150 ml/nin/L.?3 m2
Clearance
( crcl)
33. TTa 3.0-7.5 ncg/d1
34. RT3U 2s-352
35. FTr L.3-4.2
-ooooo-
o-0. 32 umoh-L lt
2.9-8.9 nMol/L
0.19-0.42 mMol/L
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NoRMALHEMoDYNAMICvALUEsANDDERIVEDINDICES
Norrnal Va1ue Units
BP slDl* 3i:l3ti:Ei:::"ric/Mean L2o /80 te3 mm tis
co Cardiac outPut 4-6 Liters/min'
RAP Right Atria1 Pressure(u6an) 2-6 mn Hg
pAp s tD lvt illf:ffi:i"i:!i:{r:ffi:::'" 25 / L2 / 16 ron He
PCWP Pulmonary Capitlary Wedge 5-L2 mm HgPressure (mean)
cI Cardiac Index 2' 5-3 ' 5 Liters/rnin/rn2
CI=
Body Surface Area
Stroke Volume
30
60 80 mI/beat
SV=
Heat Rate
Stroke VoLume Index 30 50 rnl/beat/rn2
svr
SVI=
Body Surface Area
PulrnonarY Vascular
Resistance
MPAP - PCWP
PVR: x80
co
TPVR Total PeriPheral Vascular -5Resistarr,ce 9OO-L400 dynes ' sec ' cm "
MBP - RAPIPVR=- x 80
UU
LVSWI Left Ventricular Stroke
work rndex 
Lctr DurvnE 35-80 grm-rn7n2/beat
LVswI = (MBP-PCWP) (SVI) (.0136)
co
SV
svI
PVR
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